These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial. Barbui C, Accordini S, Nosè M, Stroup S, Purgato M, Girlanda F, Esposito E, Veronese A, Tansella M, Cipriani A, CHAT (Clozapine Haloperidol Aripiprazole Trial) Study Group. J Clin Psychopharmacol; 2011 Jun; 31(3):266-73. PubMed ID: 21508849 [Abstract] [Full Text] [Related]
7. Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia. Barber S, Olotu U, Corsi M, Cipriani A. Cochrane Database Syst Rev; 2017 Mar 23; 3(3):CD006324. PubMed ID: 28333365 [Abstract] [Full Text] [Related]
13. Benefits of combining aripiprazole to clozapine: three case reports. Rocha FL, Hara C. Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug 30; 30(6):1167-9. PubMed ID: 16647796 [Abstract] [Full Text] [Related]
18. The ABC's of dopamine receptor partial agonists - aripiprazole, brexpiprazole and cariprazine: the 15-min challenge to sort these agents out. Citrome L. Int J Clin Pract; 2015 Nov 30; 69(11):1211-20. PubMed ID: 26477545 [No Abstract] [Full Text] [Related]
20. Major changes in glucose metabolism, including new-onset diabetes, within 3 months after initiation of or switch to atypical antipsychotic medication in patients with schizophrenia and schizoaffective disorder. van Winkel R, De Hert M, Wampers M, Van Eyck D, Hanssens L, Scheen A, Peuskens J. J Clin Psychiatry; 2008 Mar 30; 69(3):472-9. PubMed ID: 18348593 [Abstract] [Full Text] [Related] Page: [Next] [New Search]